Group 1 - The core point of the article is that 中航高科 (AVIC High-Tech) held its 2025 seventh board meeting on October 24, 2025, via telecommunication, discussing the adjustment of annual allowances for independent directors [1] - For the fiscal year 2024, 中航高科's revenue composition is as follows: new materials industry accounts for 96.89%, other businesses for 1.56%, and machine tools for 1.54% [1] - As of the time of reporting, 中航高科 has a market capitalization of 32.2 billion yuan [1] Group 2 - The article mentions that the Chinese innovative drug sector has sold overseas authorizations worth 80 billion USD this year, highlighting the hot secondary market in biomedicine [1] - A dialogue with Lu Gang, a partner at Chuangdongfang Investment, indicates that while the secondary market is thriving, the primary market is facing challenges in fundraising [1]
中航高科:10月24日召开董事会会议